IL6 and pulmonary arterial hypertension: Besides, systemic inflammatory cytokines such as interleukin-3 (IL‐3) and IL‐6 were found to be increased in patients with PAH which may affect megakaryopoiesis, and leads to larger and more reactive platelets, therefore, an increase in the platelet activation indices [25].